Clinical Literature

Evidence & Resources

Peer-reviewed literature supporting the established clinical use of amniotic membrane in surgical and wound care applications.

Scientific Background

Human amniotic membrane has been used in clinical applications for over a century, with documented use dating back to the early 1900s. The tissue's unique structural and biological properties have supported its adoption across surgical, wound care, and reconstructive medicine.

Amniotic membrane is composed of an extracellular matrix that includes collagen types I, III, IV, V, and VII, along with laminin, fibronectin, and other structural proteins. This composition provides a scaffold that supports tissue integration and wound coverage in various clinical settings.

The literature referenced below reflects peer-reviewed research on the general clinical use of human amniotic membrane across multiple specialties. These studies represent category-level science and are not specific to any individual product or manufacturer.

Important Notice

The references listed above reflect published scientific literature supporting the general clinical use of human amniotic membrane. These studies are not product-specific to Arvix BioMatrix™.

Need Additional Documentation?

Our team can provide regulatory documentation, product specifications, and institutional support materials.